A New Look at Animal Models of Neurological Disorders.
作者信息
Chesselet Marie-Françoise
机构信息
Departments of Neurology and of Neurobiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
出版信息
Neurotherapeutics. 2023 Jan;20(1):1-2. doi: 10.1007/s13311-023-01366-4. Epub 2023 Apr 5.
Abstract
摘要
相似文献
1
A New Look at Animal Models of Neurological Disorders.神经系统疾病动物模型的新视角。
Neurotherapeutics. 2023 Jan;20(1):1-2. doi: 10.1007/s13311-023-01366-4. Epub 2023 Apr 5.
2
Large animal models of neurological disorders for gene therapy.用于基因治疗的神经疾病大型动物模型。
ILAR J. 2009;50(2):128-43. doi: 10.1093/ilar.50.2.128.
3
New order from neurological disorders.神经系统疾病的新秩序。
Nature. 1999 Jun 24;399(6738 Suppl):A3-5. doi: 10.1038/399a003.
4
Improving animal models for nervous system disorders.改善神经系统疾病的动物模型。
Genes Brain Behav. 2012 Aug;11(6):753-6. doi: 10.1111/j.1601-183X.2012.00808.x.
5
[Animal models in neurology: prospects and limitations].[神经病学中的动物模型：前景与局限性]
Fortschr Neurol Psychiatr. 2009 Aug;77 Suppl 1:S14-20. doi: 10.1055/s-0028-1109612. Epub 2009 Aug 14.
6
[Gene therapy in neurological diseases].[神经疾病的基因治疗]
Neurol Neurochir Pol. 2001 Nov-Dec;35(6):1111-9.
7
Animal models of neurological disorders.神经疾病的动物模型。
Neurotherapeutics. 2012 Apr;9(2):241-4. doi: 10.1007/s13311-012-0118-9.
8
Prospects of treating neurological diseases by gene therapy.基因治疗在治疗神经疾病方面的前景。
Curr Opin Investig Drugs. 2007 Jan;8(1):34-40.
9
Genetic engineering cures mice of neurological deficits: prospects for treating Angelman syndrome.
Pharmacogenomics. 2007 Jun;8(6):539-41. doi: 10.2217/14622416.8.6.539.
10
Accelerating discovery for complex neurological and behavioral disorders through systems genetics and integrative genomics in the laboratory mouse.通过实验室小鼠的系统遗传学和综合基因组学加速复杂神经和行为障碍的发现。
Neurotherapeutics. 2012 Apr;9(2):338-48. doi: 10.1007/s13311-012-0111-3.
引用本文的文献
1
Graphene nanoplatelets enhance neuronal differentiation of human bone marrow mesenchymal stem cells.石墨烯纳米片增强人骨髓间充质干细胞的神经元分化。
Biol Res. 2025 May 30;58(1):32. doi: 10.1186/s40659-025-00616-3.
本文引用的文献
1
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans.α-突触核蛋白的结构多样性与细胞环境在 α-突触核蛋白传播模型和人类中的作用。
Neurotherapeutics. 2023 Jan;20(1):67-82. doi: 10.1007/s13311-023-01365-5. Epub 2023 Apr 13.
2
Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models.胶质细胞在多聚谷氨酰胺疾病中的作用：来自患者和小鼠模型的观察。
Neurotherapeutics. 2023 Jan;20(1):48-66. doi: 10.1007/s13311-023-01357-5. Epub 2023 Apr 5.
3
Animal Models of Childhood Exposure to Lead or Manganese: Evidence for Impaired Attention, Impulse Control, and Affect Regulation and Assessment of Potential Therapies.儿童期暴露于铅或锰的动物模型：注意力、冲动控制和情感调节受损的证据，以及潜在治疗方法的评估。
Neurotherapeutics. 2023 Jan;20(1):3-21. doi: 10.1007/s13311-023-01345-9. Epub 2023 Feb 28.
4
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.由于颗粒蛋白前体突变导致额颞叶痴呆的小鼠模型的临床前干预。
Neurotherapeutics. 2023 Jan;20(1):140-153. doi: 10.1007/s13311-023-01348-6. Epub 2023 Feb 13.
5
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.一种用于测试帕金森病新疗法的小鼠模型：Thy1-aSyn（“line 61”）小鼠的最新研究进展。
Neurotherapeutics. 2023 Jan;20(1):97-116. doi: 10.1007/s13311-022-01338-0. Epub 2023 Jan 30.
6
Contribution of Intravital Neuroimaging to Study Animal Models of Multiple Sclerosis.活体神经影像学在多发性硬化动物模型研究中的贡献。
Neurotherapeutics. 2023 Jan;20(1):22-38. doi: 10.1007/s13311-022-01324-6. Epub 2023 Jan 18.
7
Putative Animal Models of Restless Legs Syndrome: A Systematic Review and Evaluation of Their Face and Construct Validity.疑似不宁腿综合征的动物模型：系统评价及其对其表面和结构效度的评估。
Neurotherapeutics. 2023 Jan;20(1):154-178. doi: 10.1007/s13311-022-01334-4. Epub 2022 Dec 19.
8
Overexpression-Induced α-Synuclein Brain Spreading.α-突触核蛋白脑内播散的过表达诱导
Neurotherapeutics. 2023 Jan;20(1):83-96. doi: 10.1007/s13311-022-01332-6. Epub 2022 Dec 13.
9
The Ties That Bind: Glial Transplantation in White Matter Ischemia and Vascular Dementia.神经胶质细胞移植在脑白质缺血和血管性痴呆中的作用
Neurotherapeutics. 2023 Jan;20(1):39-47. doi: 10.1007/s13311-022-01322-8. Epub 2022 Nov 10.
10
Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.帕金森病的溶酶体发病机制：来自 LRRK2 和 GBA1 啮齿动物模型的见解。
Neurotherapeutics. 2023 Jan;20(1):127-139. doi: 10.1007/s13311-022-01290-z. Epub 2022 Sep 9.
Zotero 插件